NfL Levels Help Predict Relapsing MS Progression & Bone Marrow Infusions and Other MS News

May 09, 2022, 12:00 AM

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how blood levels of neurofilament light chain (NfL) helped predict disease progression in multiple sclerosis patients in a Phase 3 trial.
He also reads “MS News That Caught My Eye Last Week: Bone Marrow Infusions, ATA188, Enhanced MRIs, Costs”, a column by Ed Tobias.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/